<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3015">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04667286</url>
  </required_header>
  <id_info>
    <org_study_id>1117/2020/Sper/AOUBo</org_study_id>
    <nct_id>NCT04667286</nct_id>
  </id_info>
  <brief_title>Awake Pronation for Covid-19 Treatment</brief_title>
  <official_title>Pronation in Spontaneously Breathing Patients With Acute Respiratory Failure Deu to Covid-19: Multicenter, Randomised Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Unit√† Sanitaria Locale Reggio Emilia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera di Bolzano</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliero-Universitaria di Modena</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational studies have shown that prone position (PP) in spontaneously breathing&#xD;
      patients, may improve oxygenation in individuals with Acute Respiratory Failure (ARF), due to&#xD;
      Covid-19 infection.&#xD;
&#xD;
      None so far have evaluated the clinical efficacy of this approach on the patients' outcomes&#xD;
      and in a randomised control fashion&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Observational studies have shown that prone position (PP) in spontaneously breathing&#xD;
      patients, may improve oxygenation in individuals with Acute Respiratory Failure (ARF), due to&#xD;
      Covid-19 infection.&#xD;
&#xD;
      These studies were mainly physiological and reported in a subset of patients a poor&#xD;
      tolerance. Indeed most of the beneficial effects on gas exchage disappeared in around 40% of&#xD;
      tyhe patients, once the patients regained the supine position.&#xD;
&#xD;
      None so far have evaluated the clinical efficacy of this approach on the patients' outcomes&#xD;
      and in a randomised control fashion.&#xD;
&#xD;
      This holds particularly true in those patients affected by mild de-novo ARF (PaO2/FiO2 ratio&#xD;
      within the range of 200-300), where any form of respiratory support like Continuous Positive&#xD;
      Airways Pressure (CPAP), High Flow Nasal Cannula (HFNC) or Noninvasive ventilation (NIV), may&#xD;
      be not yet indicated, especially if the patients are admitted to a regular ward as for the&#xD;
      case of Covid-19 pandemics, due to the lack of &quot;protected&quot; beds.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 30, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomised trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of day free of ventilatory support</measure>
    <time_frame>1 month</time_frame>
    <description>number of days in which the patient will not need (according to standardized criterai) any for of these ventilatory support like NIV,CPAP, HFNC or intubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes in respiratory pattern</measure>
    <time_frame>1 month</time_frame>
    <description>recording of tidal volume (when possible) and respiratory frequency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>daily changes in the ratio SaO2/FiO2</measure>
    <time_frame>1 month</time_frame>
    <description>Daily changes in oxygen saturation (SaO2) and Fraction of Inspired Oxygen (FiO2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dyspnea</measure>
    <time_frame>1 month</time_frame>
    <description>using a dedicated scale (i.e. Borg numbered from 0 to 10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>comfort during PP</measure>
    <time_frame>1 month</time_frame>
    <description>using a dedicated visual analog scale (VAS with a lenght of 20 cm)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>number of hours on PP</measure>
    <time_frame>1 month</time_frame>
    <description>recording of the actual time spent in PP</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Covid-19 Infection</condition>
  <arm_group>
    <arm_group_label>Oxygen and Prone Position (PP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oxygen via a Venturi mask in order to keep an oxygen saturation between 92 and 96% plus PP for a minimum of 10 hrs a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxygen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oxygen via a Venturi mask in order to keep an oxygen saturation between 92 and 96%</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Prone Position (PP)</intervention_name>
    <description>Prone the patients on oxygen for at least 10 hrs a day</description>
    <arm_group_label>Oxygen</arm_group_label>
    <arm_group_label>Oxygen and Prone Position (PP)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  confirmed COVID-19 infection using PCR&#xD;
&#xD;
          -  Acute Respiratory Failure ( 200 &lt;PaO2/FiO2 &lt;300) and respiratory rate &lt; 30 atti/min&#xD;
&#xD;
          -  O2 therapy initiated &lt;72 hrs&#xD;
&#xD;
          -  informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Glasgow Coma Scale (GCS) &lt; 13&#xD;
&#xD;
          -  pH&lt; 7,45, PaCO2 &gt;45 mmHg&#xD;
&#xD;
          -  need for HFNC, CPAP, NIV or intubation&#xD;
&#xD;
          -  hemodynamic instability increase of 80-90 mmHg or reduction of 30-40 mmHg in systolic&#xD;
             blood pressure&#xD;
&#xD;
          -  severe arrythmia of myocardial infarction&#xD;
&#xD;
          -  need for sedation&#xD;
&#xD;
          -  intolerance to PP&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  Body mass index (BMI) &gt; 35 kg/m2.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>stefano nava, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>stefano nava</last_name>
    <phone>+393333751828</phone>
    <email>stefanava@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>stefano nava</last_name>
    <phone>+3930512144454</phone>
    <email>stefanava@gmail.com</email>
  </overall_contact_backup>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 11, 2020</study_first_submitted>
  <study_first_submitted_qc>December 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 14, 2020</study_first_posted>
  <last_update_submitted>December 11, 2020</last_update_submitted>
  <last_update_submitted_qc>December 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</investigator_affiliation>
    <investigator_full_name>dr. Stefano Nava</investigator_full_name>
    <investigator_title>professor and chief of respiratory and critical care unit</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

